Skip to content
GLP-1 Scorecard
Menu
Graded #404

Tell Her Doc

Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Visit Tell Her DocWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$269/mo (microdose tier, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Weigh Tell Her Doc against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Tell Her Doc dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value27/100
Dose & formulation63/100
Clinical oversight76/100
Labs & monitoring52/100
Fulfillment83/100
Contract terms61/100

Strengths

  • Full compounded GLP-1 lineup — semaglutide and tirzepatide in injection, oral and orally-dissolving-tablet forms, plus microdoses
  • Names its compounding pharmacy partner (Casa Pharma RX), which is independently listed in our pharmacy registry
  • No monthly membership, cancel anytime, free discreet shipping; HSA/FSA eligible with buy-now-pay-later plans
  • Serves patients in all 50 states via a private online consultation

Where it loses points

  • 'All sales are final' — no refunds once medication has left the pharmacy
  • Exact price is plan-dependent, shown after you pick a product; advertised 'starting at $269', with a lower $140 intro on oral semaglutide
  • References LegitScript but without an independently verifiable seal — we couldn't confirm certification
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Bottom line — Grade C

Best for: Shoppers who want women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy.

Ranked #404 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Tell Her Doc — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Tell Her Doc's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Tell Her Doc's site. Not medical advice; see our disclosure.

← Back to the scorecard